Global Biotech Ingredients Market Expected to Reach USD 94.5 Billion by 2033 - IMARC Group

Global Biotech Ingredients Market Statistics, Outlook and Regional Analysis 2025-2033

The global biotech ingredients market size was valued at USD 62.1 Billion in 2024, and it is expected to reach USD 94.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.29% from 2025 to 2033.

The rising usage of biotechnology in the beauty and personal care industry is positively impacting biotech ingredients market growth. In contrast, the increasing consumer awareness about environmental sustainability and the demand for innovative, natural, and eco-friendly products are gaining traction for biotech-based solutions. Companies are leveraging advanced fermentation technologies and bioengineering to develop bio-based ingredients that align with regulations and meet diverse consumer demands. For example, in October 2024, the LOreal Group partnered with Evonik and Abolis Biotechnologies to launch innovative biotech-based ingredients for beauty products. This partnership focuses on renewable, sustainable ingredients that reduce waste, conserve resources, and advance LOreal’s sustainability goals. On the contrary, the role of key market players in enabling accessibility to biotechnology platforms and reducing barriers to innovation is further bolstering the growth. For instance, in July 2024, Debut Biotechnology launched BiotechXBeautyLabs, offering sustainable, 95% bio-based biotech ingredients and formulations to beauty brands worldwide. This platform eliminates the need for upfront research costs, allowing brands to accelerate product development while adhering to regulatory standards. These types of initiatives are strengthening innovation in the skincare, haircare, and body care industry by providing scalable solutions that address growing consumer expectations for personalized and sustainable beauty products.

Moreover, the market is experiencing significant innovations in fermentation technology for biotech-based ingredients across multiple industries. For example, BASF's Isobionics unveiled a biotech-based natural flavor developed through advanced fermentation. This ingredient is free from clove derivatives, pesticides, and agricultural residues that meet EU and US regulations, thereby ensuring premium quality and diverse applications in beverages, food, and fragrances. This innovation reflects the broader trend of employing biotech solutions to replace traditional, resource-intensive production methods, thereby highlighting the versatility and scalability of biotechnology in creating sustainable alternatives. Overall, these ongoing advancements underline the biotech ingredient industry’s robust growth.

Global Biotech Ingredients Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe dominates the biotech ingredients market due to strong innovation, stringent regulations promoting sustainable practices, and rising demand for eco-friendly solutions.

North America Biotech Ingredients Market Trends:

In North America, the market is advancing due to strong investment in biopharmaceutical production, with the U.S. leading. Moreover, companies like Amgen focus on monoclonal antibodies, which is driving the demand for advanced fermentation technologies. Also, the region benefits from robust research funding, exemplified by NIH grants supporting biosimilars. Meanwhile, rising demand for biologics in cancer treatment further boosts market expansion in the United States and Canada.

Europe Biotech Ingredients Market Trends:

Europe is the leading region in the market, driven by its advanced research facilities and consumer preference for natural, science-backed products, further supporting its dominance. For instance, Evolva introduced its Responsible Care program at the in-cosmetics trade fair in Barcelona in March 2023, highlighting biotech-derived resveratrol (Juneo) and L-arabinose (Larally). These ingredients target skin aging and microbiome health, addressing growing sustainability trends and mindful consumer needs. This launch aligns with Europe’s focus on sustainable personal care, bolstering its leadership in this market. Besides this, the region's robust regulatory framework ensures the safety and efficacy of these innovative solutions.

Asia Pacific Biotech Ingredients Market Trends:

Asia Pacific is growing rapidly due to low-cost manufacturing and high demand for biotech-based generics. China leads in recombinant protein production, supported by its expanding biologics sector. For instance, Wuxi Biologics’ facility developments highlight the region’s focus on biologics outsourcing. Furthermore, India’s robust contract manufacturing services also boost the market, with partnerships catering to global pharmaceutical giants.

Latin America Biotech Ingredients Market Trends:

In Latin America, the market is witnessing growth in biotech ingredients due to increasing biosimilar adoption. Brazil’s biopharma companies like Biolab are expanding their biotech portfolios, driven by government-backed healthcare initiatives. Besides this, rising investments in R&D for diabetes and oncology biologics showcase the region's potential, and regulatory support, such as ANVISA’s biosimilar approval framework, further accelerates the market growth.

Middle East and Africa Biotech Ingredients Market Trends:

The Middle East and Africa are progressing due to growing biotech hubs in countries like South Africa. On the contrary, partnerships, such as Aspen Pharmacare collaborating on vaccine production, are spurring regional development. Also, increased focus on tackling infectious diseases through biotech solutions aligns with regional health priorities. Moreover, the UAE’s investment in biosynthetic insulin highlights innovative advancements catering to diabetes management in this region.

Top Companies Leading in the Biotech Ingredients Industry

Some of the leading biotech ingredients market companies include AbbVie Inc., Advanced Biotech, Amyris Inc., Becton Dickinson and Company, Bell Flavors & Fragrances Inc., Bruker Corporation, Evolva AG, Evonik Industries AG, GlaxoSmithKline plc., International Flavors & Fragrances Inc., Merck KGaA, and Sanofi SA, among many others. In February 2024, Evonik introduced Vecollage Fortify L, a biotech-based vegan collagen, leveraging fermentation technology for ethical, sustainable skincare solutions. Developed with Modern Meadow Inc., this skin-identical collagen enhances elasticity and hydration, meeting rising demand for non-animal, sustainable active ingredients in beauty products.

Global Biotech Ingredients Market Segmentation Coverage

• On the basis of the type, the market has been bifurcated into yeast, algae, and others, wherein algae represents the most preferred segment. Algae-based ingredients are extensively leveraged in key sectors such as food, as they are rich in essential fatty acids, antioxidants, and vitamins, pharmaceuticals, and cosmetics.
• Based on the application, the market is categorized into food and beverages, personal care and cosmetics, cleaning products, and others, amongst which personal care and cosmetics dominate the market. The heightening demand for effective, sustainable, and safe cosmetics has significantly fueled the adoption of biotech-based ingredients, including enzymes, hyaluronic acid, and peptides.